Table 1.
Selected characteristics and findings in three trials that evaluated intensive blood pressure lowering in stroke survivors.
Intensive Therapy | Standard Therapy | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Trial | Sample size |
Mean Age, y |
Follow-up, y |
Primary outcome |
Target BP |
Achieved BP |
Stroke events |
Target BP |
Achieved BP |
Stroke events |
SPS3 [17] | 3020 | 63 | 3.7 | Stroke | <130 | 12/7 | 125 | 130-149 | 138 | 152 |
RESPECT [18] | 1263 | 67 | 3.9 | Stroke | <120/80 | 127/77 | 39 | <140/90 | 133/78 | 52 |
PAST-BP [19] | 83 | 72 | 1.0 | BP | <130* | 127/72 | 0 | <140 | 129/74 | 3 |
PODCAST [20] | 83 | 74 | 2.0 | Cognitive function | <125 | 130/73† | 1 | <140 | 140/77† | 3 |
Total strokes | 165 | Total strokes | 210 |
SPS3=Secondary Prevention of Small Cortical Strokes; RESPECT=Recurrent Stroke Prevention Clinical Outcome; PAST-BP=Prevention After Stroke-Blood Pressure.
or SBP reduction >10 mm Hg if starting SBP was <140 mm Hg.
at the six-month visit